You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Evaluating Serum Thymidine Kinase 1 in Hormone Receptor Positive Metastatic Breast Cancer Patients Receiving First Line Endocrine Therapy in the SWOG S0226 Trial
|
|---|---|
| Published in |
Clinical Cancer Research, September 2021
|
| DOI | 10.1158/1078-0432.ccr-21-1562 |
| Pubmed ID | |
| Authors |
Costanza Paoletti, William E Barlow, Erin F Cobain, Mattias Bergqvist, Rita S Mehta, Julie R Gralow, Gabriel N Hortobagyi, Kathy S Albain, Lajos Pusztai, Priyanka Sharma, Andrew K Godwin, Alastair M Thompson, Daniel F Hayes, James M Rae |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 46% |
| United Kingdom | 1 | 8% |
| Sweden | 1 | 8% |
| Unknown | 5 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 92% |
| Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 12 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 1 | 8% |
| Professor | 1 | 8% |
| Student > Postgraduate | 1 | 8% |
| Unknown | 9 | 75% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 1 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 8% |
| Medicine and Dentistry | 1 | 8% |
| Unknown | 9 | 75% |
Attention Score in Context
This research output has an Altmetric Attention Score of 144. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2022.
All research outputs
#285,183
of 25,340,976 outputs
Outputs from Clinical Cancer Research
#121
of 13,216 outputs
Outputs of similar age
#7,249
of 424,978 outputs
Outputs of similar age from Clinical Cancer Research
#7
of 113 outputs
Altmetric has tracked 25,340,976 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,216 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,978 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 113 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.